Continuing Titration: For individuals who, in consultation with their provider, require continued titration and are tolerating the medication well, proceeding to a higher dose is a standard clinical approach
Coverage gap highlighted The Doran case illustrates a structural feature of Canadian public coverage flagged by the BBC: provincial drug programs that cover semaglutide for one indication may not cover it for another
Carnitine is transferred across the placenta, primarily during the third trimester, so preterm infants often develop carnitine deficiencies
Thats been, like, another big, concerning thing among clinicians cause when you think about weight loss, whether its through a GLP-1 drug, exercise, diet or something like malnutrition, youre losing all different, quote, unquote, types of weight